Bhargava Kandala

3PUBLICATIONS
2CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 03, 2026
Population Pharmacokinetic, Exposure-Response Efficacy and Safety Analyses of Favezelimab in Patients With Solid Tumors.

|May 20, 2024
Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.

Andrew J Armstrong, Ravit Geva, Hyun Cheol Chung

|Feb 07, 2024
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial.

Andrew J Armstrong, Ravit Geva, Hyun Cheol Chung

Pageof 1

Frequent Collaborators

2 joint publications

Andrew J Armstrong

2 joint publications

Tae Min Kim